Iradimed (IRMD) Depreciation and Depletion (2013 - 2026)

Iradimed (IRMD) has 14 years of Depreciation and Depletion data on file, last reported at $291000.0 in Q1 2026.

• On a quarterly basis, Depreciation and Depletion rose 117.16% year-over-year to $291000.0 in Q1 2026; TTM through Mar 2026 was $952642.0, a 72.79% increase from a year earlier, with the FY2025 full-year figure at $796000.0, up 35.84% from the prior year.
• Depreciation and Depletion for Q1 2026 stood at $291000.0, up from $269660.0 in the prior quarter.
• Over the last five years, Depreciation and Depletion for IRMD reached as high as $291000.0 in Q1 2026 and fell as low as $134000.0 in Q1 2025.
• Historically, Depreciation and Depletion has averaged $170015.4 across 5 years, with a median of $149581.0 in 2022.
• Across the five-year window, Depreciation and Depletion dropped 20.55% in 2025 and jumped 117.16% in 2026, its largest moves.
• Year by year, Depreciation and Depletion stood at $149581.0 in 2022, then grew by 9.67% to $164039.0 in 2023, then decreased by 17.21% to $135806.0 in 2024, then surged by 98.56% to $269660.0 in 2025, then advanced by 7.91% to $291000.0 in 2026.
• Per Business Quant data, the three most recent Depreciation and Depletion figures were $291000.0 in Q1 2026, $269660.0 in Q4 2025, and $256312.0 in Q3 2025.